Andrew Fox

Drug maker Neurim Pharmaceuticals is battling to amend its Australian patent for the blockbuster sleeping pill Circadin over opposition from two generic pharmaceutical companies, which have accused Neurim of attempting to gain an unfair advantage by delaying the amendment bid until now.

Gaming giant Aristocrat Technologies is seeking damages in the “high tens of millions of dollars” from rival Konami Australia, after the poker machine developer was found liable for patent infringement.